Harbour Investments’s Medifast MED Stock Holding History

Harbour Investments’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-176	Closed	-$3.37K	–	3550
2024 Q3	$3.37K	Sell	176 -39	-18%	-$751	﹤0.01%	2763
2024 Q2	$4.69K	Hold	215	–	–	﹤0.01%	2540
2024 Q1	$8.24K	Sell	215 -1	-0.5%	-$48	﹤0.01%	2297
2023 Q4	$14.5K	Sell	216 -2	-0.9%	-$139	﹤0.01%	2008
2023 Q3	$16.3K	Hold	218	–	–	﹤0.01%	1830
2023 Q2	$20.1K	Hold	218	–	–	﹤0.01%	1755
2023 Q1	$22.6K	Hold	218	–	–	﹤0.01%	1687
2022 Q4	$25.1K	Sell	218 -34	-13%	-$3.96K	﹤0.01%	1585
2022 Q3	$46K	Hold	252	–	–	﹤0.01%	1298
2022 Q2	$46K	Buy	+252	New	+$45.1K	﹤0.01%	1298
2021 Q4	$64K	Sell	305 -176	-37%	-$36.4K	﹤0.01%	1151
2021 Q3	$93K	Sell	481 -27	-5%	-$6.64K	﹤0.01%	1419
2021 Q2	$144K	Sell	508 -696	-58%	-$189K	﹤0.01%	1203
2021 Q1	$255K	Buy	+1,204	New	+$288K	0.01%	872

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Harbour Investments's MED Position: Q4 2024 in Review

Harbour Investments sold out of Medifast (MED) in Q4 2024, closing a stake of 176 shares — an estimated $3.37K sold.

Harbour Investments first reported a position in MED in Q1 2021 and held it in 14 quarters. The position peaked at $255K in Q1 2021. 129 funds tracked by Wall St. Rank hold MED as of Q4 2024.

Harbour Investments reported no remaining Medifast position as of Q4 2024 after selling out during the quarter.
Harbour Investments sold 176 Medifast shares in Q4 2024, an estimated $3.37K.
Harbour Investments first reported a position in Medifast in Q1 2021 and held it in 14 quarters.
Harbour Investments's Medifast position peaked at $255K in Q1 2021.
129 funds tracked by Wall St. Rank held Medifast as of Q4 2024.

Based on Harbour Investments's 13F filing for Q4 2024, filed 10 Feb 2025.